912 filings
Page 37 of 46
8-K
ARMP
Armata Pharmaceuticals, Inc.
9 May 06
Material Modifications to Rights of Security Holders
12:00am
10-Q
2006 Q1
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
4 May 06
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
2 May 06
Targeted Genetics Reports First Quarter 2006 Financial Results
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
28 Apr 06
Zambia Begins First Preventive Hiv Vaccine Trial
12:00am
ARS
2005 FY
ARMP
Armata Pharmaceuticals, Inc.
19 Apr 06
Annual report to shareholders
12:00am
DEF 14A
ARMP
Armata Pharmaceuticals, Inc.
Definitive proxy
29 Mar 06
12:00am
PRE 14A
ARMP
Armata Pharmaceuticals, Inc.
Preliminary proxy
17 Mar 06
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
16 Mar 06
Other Events
12:00am
10-K
2005 FY
ARMP
Armata Pharmaceuticals, Inc.
Annual report
16 Mar 06
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
15 Mar 06
Targeted Genetics Completes $5.0 Million Public Offering of Common Stock
12:00am
FWP
ARMP
Armata Pharmaceuticals, Inc.
10 Mar 06
Free writing prospectus
12:00am
424B5
ARMP
Armata Pharmaceuticals, Inc.
10 Mar 06
Prospectus supplement for primary offering
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
10 Mar 06
Targeted Genetics Announces $5.0 Million Public Offering of Common Stock
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
9 Mar 06
Targeted Genetics Reports Fourth Quarter and Year-end 2005 Financial Results
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
8 Mar 06
Entry into a Material Definitive Agreement
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
25 Jan 06
Targeted Genetics Announces Strategic Restructuring to Reduce Expenses and Advance Lead Inflammatory Arthritis Product Candidate
12:00am
8-K/A
ARMP
Armata Pharmaceuticals, Inc.
19 Jan 06
Targeted Genetics Appoints David J. Poston As Chief Financial Officer
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
30 Nov 05
Targeted Genetics Named As Subcontractor to Niaid Contract to Expand Aav-based Hiv Vaccine Program
12:00am
8-K
ARMP
Armata Pharmaceuticals, Inc.
16 Nov 05
IAVI Begins First Phase II Preventive HIV Vaccine Trial in South Africa to Test Targeted Genetics’ HIV Vaccine Candidate
12:00am
10-Q
2005 Q3
ARMP
Armata Pharmaceuticals, Inc.
Quarterly report
3 Nov 05
12:00am